Generali Investments CEE’s Takeda Pharmaceutical TAK Stock Holding History

Generali Investments CEE’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Hold	10,000	–	–	0.01%	431
2026 Q1	$185K	Hold	10,000	–	–	0.01%	420
2025 Q4	$156K	Hold	10,000	–	–	0.01%	368
2025 Q3	$146K	Hold	10,000	–	–	0.01%	359
2025 Q2	$155K	Hold	10,000	–	–	0.01%	346
2025 Q1	$149K	Hold	10,000	–	–	0.01%	342
2024 Q4	$132K	Buy	+10,000	New	+$137K	0.01%	318

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Generali Investments CEE's TAK Position: Q2 2026 in Review

Generali Investments CEE held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 10,000 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #431.

Generali Investments CEE first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. The position peaked at $185K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Generali Investments CEE held 10,000 shares of Takeda Pharmaceutical worth $160K as of Q2 2026.
Generali Investments CEE left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Generali Investments CEE's portfolio in Q2 2026, its #431 holding.
Generali Investments CEE first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Generali Investments CEE's Takeda Pharmaceutical position peaked at $185K in Q1 2026.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.